A Phase IIa Study in Primary IgA Nephropathy Patients

NCT07634744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: XH-S003 Capsule

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.